These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 6756941

  • 21. Potentiation of phencyclidine-induced stereotyped behaviors in rats by thiorphan and bestatin.
    Hiramatsu M, Nabeshima T, Fukaya H, Furukawa H, Kameyama T.
    Eur J Pharmacol; 1986 Jan 14; 120(1):69-74. PubMed ID: 3456306
    [Abstract] [Full Text] [Related]

  • 22. Involvement of endogenous enkephalins in the mouse 'behavioral despair' test.
    Natan LB, Chaillet P, Lecomte JM, Marçais H, Uchida G, Costentin J.
    Eur J Pharmacol; 1984 Jan 27; 97(3-4):301-4. PubMed ID: 6584312
    [Abstract] [Full Text] [Related]

  • 23. Enkephalinase 'A' inhibition by thiorphan: central and peripheral cardiovascular effects.
    Baum T, Becker FT, Sybertz EJ, Sabin C, Desiderio DM.
    Eur J Pharmacol; 1983 Oct 14; 94(1-2):85-91. PubMed ID: 6360696
    [Abstract] [Full Text] [Related]

  • 24. Depressive effects of morphine and of an enkephalinase inhibitor on responses of ventro-basal thalamic neurones to noxious stimuli.
    Guilbaud G, Kayser V, Benoist JM, Gautron M.
    Life Sci; 1983 Oct 14; 33 Suppl 1():545-7. PubMed ID: 6363853
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The inactivation of [Met5]-enkephalin by bestatin-sensitive aminopeptidase, captopril-sensitive peptidyl dipeptidase A and thiorphan-sensitive endopeptidase-24.11 in mouse vas deferens.
    Aoki K, Kajiwara M, Oka T.
    Jpn J Pharmacol; 1986 Feb 14; 40(2):297-302. PubMed ID: 3009948
    [Abstract] [Full Text] [Related]

  • 27. Inhibition of enkephalinase activity attenuates naloxone-precipitated withdrawal symptoms.
    Haffmans J, Dzoljic MR.
    Gen Pharmacol; 1987 Feb 14; 18(1):103-5. PubMed ID: 3549428
    [Abstract] [Full Text] [Related]

  • 28. Enantiomers of [R,S]-thiorphan: dissociation of analgesia from enkephalinase A inhibition.
    Scott WL, Mendelsohn LG, Cohen ML, Evans DA, Frederickson RC.
    Life Sci; 1985 Apr 01; 36(13):1307-13. PubMed ID: 2984500
    [Abstract] [Full Text] [Related]

  • 29. Opioid activity of enkephalin analogues containing the kyotorphin-related structure in the N-terminus.
    Amano H, Morimoto Y, Kaneko S, Takagi H.
    Neuropharmacology; 1984 Apr 01; 23(4):395-400. PubMed ID: 6328351
    [Abstract] [Full Text] [Related]

  • 30. Pharmacology of SCH 34826, an orally active enkephalinase inhibitor analgesic.
    Chipkin RE, Berger JG, Billard W, Iorio LC, Chapman R, Barnett A.
    J Pharmacol Exp Ther; 1988 Jun 01; 245(3):829-38. PubMed ID: 3164388
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Central and peripheral involvement of endogenous opioid peptides in gastric protection in stressed rats.
    Scoto GM, Parenti C.
    Pharmacology; 1996 Jan 01; 52(1):56-60. PubMed ID: 8966203
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Naloxone-reversible antidiarrheal effects of enkephalinase inhibitors.
    Marçais-Collado H, Uchida G, Costentin J, Schwartz JC, Lecomte JM.
    Eur J Pharmacol; 1987 Dec 01; 144(2):125-32. PubMed ID: 3481337
    [Abstract] [Full Text] [Related]

  • 35. Influence of enkephalinase inhibitors on gastric emptying in mice depends on the nature of the meal.
    Liberge M, Rivière PM, Buéno L.
    Life Sci; 1988 Dec 01; 42(21):2047-53. PubMed ID: 3164437
    [Abstract] [Full Text] [Related]

  • 36. Analgesic effects of kelatorphan, a new highly potent inhibitor of multiple enkephalin degrading enzymes.
    Fournie-Zaluski MC, Chaillet P, Bouboutou R, Coulaud A, Cherot P, Waksman G, Costentin J, Roques BP.
    Eur J Pharmacol; 1984 Jul 20; 102(3-4):525-8. PubMed ID: 6386492
    [Abstract] [Full Text] [Related]

  • 37. Thiorphan and analogs: lack of correlation between potency to inhibit "enkephalinase A" in vitro and analgesic potency in vivo.
    Mendelsohn LG, Johnson BG, Scott WL, Frederickson RC.
    J Pharmacol Exp Ther; 1985 Aug 20; 234(2):386-90. PubMed ID: 3894620
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effects of ES52, an enkephalinase inhibitor, on responses of ventrobasal thalamic neurons in rat.
    Kayser V, Benoist JM, Gautron M, Guilbaud G.
    Peptides; 1984 Aug 20; 5(6):1159-65. PubMed ID: 6397732
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.